A multi-biomarker follow-up study of patients with multiple sclerosis.

Brain Behav · 2016 · PMC5036432 · PMID 27688939

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In our survival time analysis, the clinical assessment and biomarker evaluation showed a trend as indicators of risk of future DA which should be further developed and validated for accuracy in larger prospective cohorts of patients with MS and CIS.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.